D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$497M |
| 2 |
Bank of America
BAC
|
$342M |
| 3 |
Costco
COST
|
$332M |
| 4 |
Procter & Gamble
PG
|
$332M |
| 5 |
Meta Platforms (Facebook)
META
|
$305M |
Top Sells
| 1 |
Marathon Petroleum
MPC
|
$504M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$387M |
| 3 |
Pfizer
PFE
|
$366M |
| 4 |
Advanced Micro Devices
AMD
|
$331M |
| 5 |
Walmart
WMT
|
$320M |
Sector Composition
| 1 | Technology | 17.19% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Iovance Biotherapeutics
IOVA
$901M
| $22.9M | 0.03% |
2,077,531
+1,952,904
| +1,567% | +$21.6M |
|
|
DRAY
452
DELISTED
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
| $22.9M | 0.03% |
2,304,664
| – | – |
|
453
Materials Select Sector SPDR Fund
XLB
$5.52B
| $22.8M | 0.03% |
310,000
+256,100
| +475% | +$18.8M |
|
454
Healthcare Realty
HR
$6.35B
| $22.8M | 0.03% |
816,288
-547,541
| -40% | -$15.3M |
|
|
IPOF
455
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
| $22.8M | 0.03% |
2,291,531
| – | – |
|
|
GTM
456
ZoomInfo Technologies
GTM
$3.26B
| $22.7M | 0.03% |
682,490
+218,306
| +47% | +$7.26M |
|
457
Resideo Technologies
REZI
$5.32B
| $22.4M | 0.03% |
1,153,188
-164,206
| -12% | -$3.19M |
|
|
CONX
458
DELISTED
CONX Corp. Class A Common Stock
CONX
| $22.3M | 0.03% |
2,256,807
-103,785
| -4% | -$1.03M |
|
459
BridgeBio Pharma
BBIO
$10.2B
| $22.2M | 0.03% |
2,448,459
-47,569
| -2% | -$432K |
|
|
MAXR
460
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $22.2M | 0.03% |
852,591
+47,254
| +6% | +$1.23M |
|
461
Centene
CNC
$14.2B
| $22.2M | 0.03% |
262,220
+172,575
| +193% | +$14.6M |
|
462
Intellia Therapeutics
NTLA
$1.29B
| $22.1M | 0.03% |
426,350
+207,941
| +95% | +$10.8M |
|
463
BCE
BCE
$23.1B
| $22M | 0.03% |
448,476
+256,700
| +134% | +$12.6M |
|
|
RBCP
464
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $21.9M | 0.03% |
230,000
+105,000
| +84% | +$10M |
|
465
Vistra
VST
$63.7B
| $21.9M | 0.03% |
+958,716
| New | +$21.9M |
|
466
Brookfield
BN
$99.5B
| $21.8M | 0.03% |
605,674
+496,986
| +457% | +$17.9M |
|
467
Frontier Communications
FYBR
$9.33B
| $21.8M | 0.03% |
924,464
+294,167
| +47% | +$6.92M |
|
468
Zillow
ZG
$20.5B
| $21.7M | 0.03% |
682,922
-184,407
| -21% | -$5.87M |
|
469
Dick's Sporting Goods
DKS
$17.7B
| $21.7M | 0.03% |
287,435
-4,565
| -2% | -$344K |
|
|
WRAC
470
DELISTED
Williams Rowland Acquisition Corp.
WRAC
| $21.6M | 0.03% |
2,158,469
+1,160
| +0.1% | +$11.6K |
|
471
Digital Realty Trust
DLR
$55.7B
| $21.5M | 0.03% |
165,896
+164,212
| +9,751% | +$21.3M |
|
472
Hartford Financial Services
HIG
$37B
| $21.5M | 0.03% |
328,567
-189,055
| -37% | -$12.4M |
|
473
Ultragenyx Pharmaceutical
RARE
$3.07B
| $21.4M | 0.03% |
359,517
-124,821
| -26% | -$7.45M |
|
474
SandRidge Energy
SD
$420M
| $21.4M | 0.03% |
1,368,104
+245,585
| +22% | +$3.85M |
|
475
Neurocrine Biosciences
NBIX
$14.3B
| $21.4M | 0.03% |
219,737
-1,196
| -0.5% | -$117K |
|